Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Firm Income Reported for This Client
$300K
Not substituted for client expenses
Summary
MCDERMOTT WILL & EMERY LLP (OBO ALNYLAM PHARMACEUTICALS) is an organization, based in CA. Its political footprint includes $300K in lobbying-firm income reported for this client. Lobbying activity focuses on Medicare/Medicaid, Health Issues, Copyright/Patent/Trademark. Political activity spans from 2022 to 2023.